LONDON (Alliance News) - <strong>Aviva</strong> has Monday agreed to sell its 47% stake in its South Korean joint venture Woori Aviva Life Insurance to NongHyup Financial Group, as it continues to contract in the region and focus on markets where it can make the best returns on capital. <br /> Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning: ---------- FTSE 100 ---------- UBS REMOVED SCHRODERS FROM LEAST PREFERRED LIST ---------- UBS RAISES SCHRODERS PRICE TARGET TO 2700 (2650) PENCE - 'NEUTRAL' Read More
LONDON (Alliance News) - Glencore Xstrata said Monday it has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash. The deal is part of an agreement to w Read More
LONDON (Alliance News) - UK stocks are set to open firmly lower Monday, following another sharp sell-off on Wall Street on Friday and a weak Asian session overnight, and as increasing tensions in Ukraine are also likely to hurt investor sentiment. Wall Street continued its recent down trend Read More
LONDON (Alliance News) - UK-based drugmaker GlaxoSmithKline PLC is facing a criminal probe in Poland for allegedly paying bribes to doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. According to the report, eleven doctors and one of Glaxo's regional managers have Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Friday said that the following executive directors and managers acquired shares at a price of 1585.037 pence per share on Thursday, via a dividend reinvestment.<br /><br /> <table class="u" cellspacing="0" cellpadding="0"><tbody><tr><td class="k" Read More
LONDON (Alliance News) - Glaxosmithkline PLC Thursday said senior executives, including Chief Executive Andrew Witty and Chief Financial Officer Simon Dingermans, acquired shares under the company share reward plan at a price of 1572.79 pence Wednesday.<br /><br />Details are as follows<br />< Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday backed flu treatment Relenza after a report from The Cochrane Collaboration suggested that it and Swiss healthcare company Roche Holdings AG's treatment Tamiflu have little effect. The implications of the report are significant as govern Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares as part of a dividend reinvestment of shares held within an ISA at a price of 1583.14 pence per share Friday.<br /><br />Details are as follows.<br /><br />< Read More
LONDON (Alliance News) - London's major stock indices closed firmly in the red Monday, led lower by technology stocks, following on from an equity sell-off on Wall Street on Friday.<br /><br />Meanwhile, concerns over a possible further encroachment into Ukraine by Russia also weighed heavily Read More
LONDON (Alliance News) - Pharmaceuticals giant <strong>GlaxoSmithKline</strong> has confirmed that is investigating allegations of improper conduct in its Iraq business.<br /><br />The Wall Street Journal had cited a person familiar with the matter saying that Glaxo was violating US and UK ant Read More
LONDON (Alliance News) - GlaxoSmithKline PLC is investigating allegations of improper conduct in its Iraq business, a spokesperson for the company confirmed Monday. "We have zero tolerance for unethical or illegal behaviour," the spokesperson said in a statement. The spokesperson note Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />British drugmaker<strong> GlaxoSmithKline</strong> PLC is investigating claims of improper conduct related to its business in Iraq, less than a y Read More
LONDON (Alliance News) - Weak leads from the US and Asia have combined with continued tensions in the Ukraine to depress UK shares at the open Monday.<br /><br />Among UK corporate news at the start of the week, <strong>Kentz</strong> said it has been awarded a USD570 million services contract Read More
LONDON (Alliance News) - British drugmaker GlaxoSmithKline is investigating claims of improper conduct related to its business in Iraq, less than a year after China accused Glaxo of engaging in a bribery scheme aimed at increasing drug sales there, the New York Times reports. The Wall Stree Read More